These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17996416)

  • 21. T1 glottic carcinoma involving the posterior commissure.
    Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
    Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck.
    Sheridan MT; O'Dwyer T; Seymour CB; Mothersill CE
    Radiat Oncol Investig; 1997; 5(4):180-6. PubMed ID: 9327497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
    Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radiotherapy of carcinoma of the glottis in the initial stage].
    Neri S; Belli A; Caliceti U; Emiliani E; Frezza G; Palazzi Trivelli A; Silvano M; Zini G; Babini L; Barbieri E
    Radiol Med; 1987 Oct; 74(4):338-40. PubMed ID: 3671804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of p53 expression in the primary lesion and the surgical margin on the postoperative radiotherapy for laryngeal squamous carcinoma].
    Xia LP; Zeng ZY; Guo ZM; Rao HL; Zeng J; Xu GP; Hou JH
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):558-61. PubMed ID: 14690561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ki-67 expression predicts radiotherapy failure in early glottic cancer.
    Nichols AC; Whelan F; Basmaji J; Dhaliwal S; Dowthwaite S; Chapeskie C; Read N; Palma DA; Fung K; Venkatesan V; Hammond JA; Franklin JH; Siddiqui I; Wehrli B; Kwan K; Koropatnick J; Mymryk JS; Barrett JW; Yoo J
    J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):124-30. PubMed ID: 22569013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T1 glottic carcinoma involving the anterior commissure.
    Shvero J; Hadar T; Segal K; Yaniv E; Marshak G; Feinmesser R
    Eur J Surg Oncol; 1994 Oct; 20(5):557-60. PubMed ID: 7926059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
    Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
    J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
    Calli C; Calli A; Pinar E; Oncel S; Demirtaşoğlu F
    Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):9-13. PubMed ID: 16340285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
    Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
    Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
    Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
    Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical markers in the morphological diagnosis of lung carcinoma.
    Cornianu M; Tudose N
    Rom J Morphol Embryol; 1997; 43(3-4):181-91. PubMed ID: 9747120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy.
    Parikh RR; Yang Q; Haffty BG
    Cancer; 2007 Feb; 109(3):566-73. PubMed ID: 17183558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy.
    Holgersson G; Ekman S; Reizenstein J; Bergqvist M; Pontén F; Uhlén M; Magnusson K; Jonnalagadda P; Asplund A; Strömberg S; Linder A; Blomquist E; Liljeholm M; Lödén B; Hellström K; Bergström S
    Cancer Genomics Proteomics; 2010; 7(1):1-7. PubMed ID: 20181625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer.
    Kitamura K; Saeki H; Kawaguchi H; Araki K; Ohno S; Kuwano H; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2000; 47(32):419-23. PubMed ID: 10791203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
    Katori H; Nozawa A; Tsukuda M
    Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.
    Reddy SP; Hong RL; Nagda S; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1389-94. PubMed ID: 17869013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of p53, Ki-67, and EGFR in odontogenic keratocysts before and after decompression.
    Clark P; Marker P; Bastian HL; Krogdahl A
    J Oral Pathol Med; 2006 Oct; 35(9):568-72. PubMed ID: 16968238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.